A Benoit, E Bou-Petit, H Chou, M Lu, C Guilbert… - Scientific Reports, 2022 - nature.com
Diffuse large B cell lymphoma (DLBCL) is successfully treated with combination immuno-
chemotherapy, but relapse with resistant disease occurs in~ 40% of patients. However, little …